A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

NCT03446053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Anti-Bacterial Agents
Methicillin-Resistant Staphylococcus Aureus
Methicillin-Sensitive Staphylococcus Aureus Infection

Interventions

BIOLOGICAL: N-Rephasin® SAL200
OTHER: INT200-Placebo

Sponsor

Intron Biotechnology, Inc.